{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:19:46Z","timestamp":1787840386861,"version":"build-2784847793"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The present study was performed to develop a scoring system for predicting cure status in patients with cutaneous leishmaniasis (CL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This study included 199 patients with CL from Skin Diseases and Leishmaniasis Research Center (Isfahan, Iran). Data were collected as longitudinal in each visit of patients. We applied ordinal logistic generalized estimating equation regression to predict score on this correlated data. To evaluate the fitted model, split sample validation method was applied. SPSS software was used for data analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The regression coefficients of the fitted model were used to calculate score for cure status. Based on split-sample validation method, overall correct classification rate was 82%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study suggested a scoring system predict cure status in CL patients based on clinical characteristics. Using this method, score for a CL patient is easily obtained by physicians or health workers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/1735-1995.199095","type":"journal-article","created":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T04:35:43Z","timestamp":1485491743000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Development of a scoring system using a statistical model to predict cure status in patients with cutaneous leishmaniasis"],"prefix":"10.4103","volume":"22","author":[{"given":"Mehri","family":"Khoshhali","sequence":"first","affiliation":[{"name":"Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Department of Biostatistics and Epidemiology, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayed Mohsen","family":"Hosseini","sequence":"additional","affiliation":[{"name":"Skin Diseases and Leishmaniasis Research Center, Department of Biostatistics and Epidemiology, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Nilforoushzadeh","sequence":"additional","affiliation":[{"name":"Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Jaffary","sequence":"additional","affiliation":[{"name":"Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh Zolfaghari","family":"Baghbaderani","sequence":"additional","affiliation":[{"name":"Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2017,1,27]]},"reference":[{"key":"R1-20250827","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1016\/j.ijid.2011.03.021","article-title":"Recent advances in leishmaniasis treatment","volume":"15","author":"Tiuman","year":"2011","journal-title":"Int J Infect Dis"},{"key":"R2-20250827","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaad.2009.06.088","article-title":"New World cutaneous leishmaniasis: Updated review of current and future diagnosis and treatment","volume":"63","author":"Mitropoulos","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"R3-20250827","doi-asserted-by":"crossref","first-page":"e1656","DOI":"10.1371\/journal.pntd.0001656","article-title":"Prediction score for antimony treatment failure in patients with ulcerative leishmaniasis lesions","volume":"6","author":"Valencia","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"R4-20250827","first-page":"32","article-title":"Susceptibility Status of Phlebotomus papatasi and P. sergenti (Diptera: Psychodidae) to DDT and deltamethrin in a focus of cutaneous leishmaniasis after earthquake strike in bam, Iran","volume":"5","author":"Afshar","year":"2011","journal-title":"Iran J Arthropod Borne Dis"},{"key":"R5-20250827","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.0022-202x.2001.00038.x","article-title":"Leishmaniasis as an emerging infection","volume":"6","author":"Choi","year":"2001","journal-title":"J Investig Dermatol Symp Proc"},{"key":"R6-20250827","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.actatropica.2011.02.007","article-title":"Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World","volume":"118","author":"Oliveira","year":"2011","journal-title":"Acta Trop"},{"key":"R7-20250827","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4103\/0378-6323.26722","article-title":"Scoring systems in dermatology","volume":"72","author":"Bhor","year":"2006","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R8-20250827","first-page":"158","article-title":"Pemphigus area and activity score (PAAS) \u2013 A novel clinical scoring method for monitoring of pemphigus vulgaris patients","volume":"37","author":"Agarwal","year":"1998","journal-title":"Int J Dermatol"},{"key":"R9-20250827","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/archderm.1994.01690060057005","article-title":"Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial","volume":"130","author":"Kimbrough-Green","year":"1994","journal-title":"Arch Dermatol"},{"key":"R10-20250827","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"key":"R11-20250827","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/bja\/aen236","article-title":"Development and validation of a preoperative scoring system to predict 30 days mortality in patients undergoing hip fracture surgery","volume":"101","author":"Maxwell","year":"2008","journal-title":"Br J Anaesth"},{"key":"R12-20250827","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: A severity of disease classification system","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care Med"},{"key":"R13-20250827","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3102\/10769986029004421","article-title":"An introduction to generalized estimating equations and an application to assess selectivity effects in a longitudinal study on very old individuals","volume":"29","author":"Ghisletta","year":"2004","journal-title":"J Educ Behav Stat"},{"key":"R14-20250827","first-page":"235","article-title":"Comparison of generalized estimating equations and quadratic inference functions in superior versus inferior Ahmed glaucoma valve implantation","volume":"16","author":"Khajeh-Kazemi","year":"2011","journal-title":"J Res Med Sci"},{"key":"R15-20250827","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1037\/a0025813","article-title":"Fitting multilevel models with ordinal outcomes: Performance of alternative specifications and methods of estimation","volume":"16","author":"Bauer","year":"2011","journal-title":"Psychol Methods"},{"key":"R17-20250827","doi-asserted-by":"crossref","first-page":"e2130","DOI":"10.1371\/journal.pntd.0002130","article-title":"Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis","volume":"7","author":"Olliaro","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"R18-20250827","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: A severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"}],"container-title":["Journal of Research in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01222967-201722000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:21:54Z","timestamp":1787836914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01222967-201722000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.4103\/1735-1995.199095","relation":{},"ISSN":["1735-1995","1735-7136"],"issn-type":[{"value":"1735-1995","type":"print"},{"value":"1735-7136","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"2015-09-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-10-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}